Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yael Mosse
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
105 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Cancer Centre of Southeastern Ontario at Kingston General Hospital
Kingston, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- the Montreal Children'S Hospital of the Muhc
Montreal, Quebec, Canada
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Miller Children'S and Women'S Hospital Long Beach
Long Beach, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lee Memorial Health System
Fort Myers, Florida, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- Nemours Children'S Clinic - Orlando
Orlando, Florida, United States
- Uf Cancer Center at Orlando Health
Orlando, Florida, United States
- Nemours Children'S Clinic - Pensacola
Pensacola, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Saint Joseph'S Hospital/children'S Hospital-Tampa
Tampa, Florida, United States
- Children'S Healthcare of Atlanta - Egleston
Atlanta, Georgia, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Saint Jude Midwest Affiliate
Peoria, Illinois, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2011
- Primary completion
- 31 Dec 2015
- Completion
- 30 Jun 2019
- Last update posted
- 13 May 2020
- Registered enrollment
- 118
- Registry id
- NCT01154816
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.